# Induction Chemotherapy Response-Guided Radiation for EBV-Associated Nasopharyngeal Carcinoma

> **NCT06682442** · NA · RECRUITING · sponsor: **University of California, San Francisco** · enrollment: 66 (estimated)

## Conditions studied

- Nasopharyngeal Carcinoma
- Stage III Nasopharyngeal Carcinoma AJCC v8
- Stage IVA Nasopharyngeal Carcinoma AJCC v8
- Nasopharyngeal Cancer
- Nasopharyngeal Cancer Stage

## Interventions

- **RADIATION:** Intensity-Modulated Radiation Therapy (IMRT)
- **PROCEDURE:** Radiographic Imaging
- **PROCEDURE:** Biospecimen Collection

## Key facts

- **NCT ID:** NCT06682442
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-03-18
- **Primary completion:** 2029-05-31
- **Final completion:** 2032-03-31
- **Target enrollment:** 66 (ESTIMATED)
- **Last updated:** 2026-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06682442

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06682442, "Induction Chemotherapy Response-Guided Radiation for EBV-Associated Nasopharyngeal Carcinoma". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06682442. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*